Research map: mRNA Vaccines Targeting HPV E6/E7: A New Frontier in Cervical Cancer Immunotherapy

Back to the article

Papers in this map

  1. Myeloid-derived suppressor cells as regulators of the immune system · Dmitry I. Gabrilovich · 2009 · 6808 citations · Cited by this paper
  2. TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · 2026 · Related
  3. mRNA vaccines — a new era in vaccinology · Norbert Pardi · 2018 · 4712 citations · Cited by this paper
  4. Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications · 2026 · Related
  5. Papillomaviruses and cancer: from basic studies to clinical application · Harald zur Hausen · 2002 · 4062 citations · Cited by this paper
  6. Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · 2026 · Related
  7. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 · Martin Scheffner · 1990 · 4035 citations · Cited by this paper
  8. The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · 2026 · Related
  9. Lipid nanoparticles for mRNA delivery · Xucheng Hou · 2021 · 4010 citations · Cited by this paper
  10. Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine · 2026 · Related
  11. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report · Lisa A. Jackson · 2020 · 3520 citations · Cited by this paper
  12. Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy · 2026 · Related
  13. Immunogenic cell death in cancer and infectious disease · Lorenzo Galluzzi · 2016 · 3157 citations · Cited by this paper
  14. Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era · 2026 · Related
  15. The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product · Nicholas J. Dyson · 1989 · 3071 citations · Cited by this paper
  16. Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications · 2026 · Related
  17. An immunogenic personal neoantigen vaccine for patients with melanoma · Patrick Alexander Ott · 2017 · 3025 citations · Cited by this paper
  18. Liquid biopsy for early cancer detection in hereditary cancer syndromes: Current evidence · 2026 · Related
  19. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study · Silvia de Sanjosé · 2010 · 2775 citations · Cited by this paper
  20. Current status and prospects of chemotherapy-free strategies in ovarian cancer · 2026 · Related
  21. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer · Uğur Şahin · 2017 · 2539 citations · Cited by this paper
  22. mRNA-based therapeutics — developing a new class of drugs · Uğur Şahin · 2014 · 2507 citations · Cited by this paper
  23. Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability · Katalin Karikó · 2008 · 1958 citations · Cited by this paper
  24. Human papillomavirus oncoproteins: pathways to transformation · Cary A. Moody · 2010 · 1781 citations · Cited by this paper
  25. Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape · Jérôme Gilleron · 2013 · 1667 citations · Cited by this paper
  26. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial · Diane Medved Harper · 2004 · 1648 citations · Cited by this paper
  27. The Biology and Life-Cycle of Human Papillomaviruses · John Doorbar · 2012 · 1557 citations · Cited by this paper
  28. Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms · Akin Akinc · 2010 · 1267 citations · Cited by this paper
  29. Molecular biology of human papillomavirus infection and cervical cancer · John Doorbar · 2006 · 1068 citations · Cited by this paper
  30. Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines · Kimberly J. Hassett · 2019 · 939 citations · Cited by this paper
  31. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer · Valsamo Anagnostou · 2016 · 923 citations · Cited by this paper
  32. Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells · Mariet C.W. Feltkamp · 1993 · 840 citations · Cited by this paper
  33. Role of Local Radiation Therapy in Cancer Immunotherapy · Sandra Demaria · 2015 · 808 citations · Cited by this paper
  34. Vaccines for established cancer: overcoming the challenges posed by immune evasion · Sjoerd H. van der Burg · 2016 · 713 citations · Cited by this paper
  35. Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics · Martin A. Maier · 2013 · 641 citations · Cited by this paper
  36. mRNA Vaccine Delivery Using Lipid Nanoparticles · Andreas Michael Reichmuth · 2016 · 632 citations · Cited by this paper
  37. Lipids and Lipid Derivatives for RNA Delivery · Yuebao Zhang · 2021 · 627 citations · Cited by this paper
  38. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein · Karl Münger · 2001 · 594 citations · Cited by this paper
  39. mRNA vaccines manufacturing: Challenges and bottlenecks · Sara Sousa Rosa · 2021 · 547 citations · Cited by this paper

Source: OpenAlex (CC0)